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Background: Drug therapy in primary care is a challenge for general practitioners (GPs) and the prescribing
decision is influenced by several factors. GPs obtain drug information in different ways, from evidence-based
sources, their own or others ? experiences, or interactions with opinion makers, patients or colleagues. The need for
objective drug information sources instead of drug industry-provided information has led to the establishment of
local drug and therapeutic committees. They annually produce and implement local treatment guidelines in order
to promote rational drug use. This study describes Swedish GPs? attitudes towards locally developed evidence-based
treatment guidelines.
Methods: Three focus group interviews were performed with a total of 17 GPs working at both public and private
primary health care centres in Sk?ne in southern Sweden. Transcripts were analysed by conventional content analysis.
Codes, categories and themes were derived from data during the analysis.
Results: We found two main themes: GP-related influencing factors and External influencing factors. The first theme
emerged when we put together four main categories: Expectations and perceptions about existing local guidelines,
Knowledge about evidence-based prescribing, Trust in development of guidelines, and Beliefs about adherence to guidelines.
The second theme included the categories Patient-related aspects, Drug industry-related aspects, and Health economic
aspects. The time-saving aspect, trust in evidence-based market-neutral guidelines and patient safety were described as
key motivating factors for adherence. Patient safety was reported to be more important than adherence to guidelines
or maintaining a good patient-doctor relationship. Cost containment was perceived both as a motivating factor and a
barrier for adherence to guidelines. GPs expressed concerns about difficulties with adherence to guidelines when
managing patients with drugs from other prescribers. GPs experienced a lack of time to self-inform and difficulties
managing direct-to-consumer drug industry information.
Conclusions: Patient safety, trust in development of evidence-based recommendations, the patient-doctor encounter
and cost containment were found to be key factors in GPs? prescribing. Future studies should explore the need for
transparency in forming and implementing guidelines, which might potentially increase adherence to evidence-based
treatment guidelines in primary care.
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Drug therapy in primary health care is a large field and a
challenge for the medical world, pharmacists, related au-
thorities and, most important of all, patients. The elderly
population is increasing and so therefore is the need and
importance of safe pharmacotherapy, with a focus on
evidence-based medicine.
The broad skills of Swedish general practitioners (GPs)
allow them to manage a vast spectrum of diseases and
problems, with care accounting for patients ? complex
needs. Following evidence-based medicine principles
while maintaining the holistic view of the individual
without risking patient safety are aspects a GP needs to
consider in every prescribing decision. The challenge of
continuously improving drug therapy while also meeting
increasing pharmaceutical costs has resulted in both na-
tional and regional reforms in Sweden. These reforms
include prescribing guidance and financial incentives in
order to improve adherence to drug therapy recommen-
dations [1]. Evidence-based treatment guidelines have
been developed and are available for both primary and
secondary care in Sweden.
GPs work in a broad medical field and therefore have
a complex way of seeking medical information, with
more direct patient-oriented care questions, which
might differ from those of colleagues in other specialities
who search for information from journals and other lit-
erature or by corresponding with colleagues [2]. How-
ever, GPs also base their decisions on ? mindlines ? , which
are collectively reinforced, internalized, tacit guidelines,
developed from own experiences or from interactions
with colleagues, patients or pharmaceutical industry repre-
sentatives [3]. This suggests that both formal and informal
networking might influence prescribing behaviour.
Although GPs are aware of the guidelines, clinical in-
ertia can lead to a conservative attitude [4]. Prescribing
behaviour can vary a lot and the causes of the variation
can be complex.
Unlike GPs in other European countries such as the
Netherlands, Denmark and Norway, Swedish GPs work
in public or tax-financed private multidisciplinary sur-
geries with several physicians, registered nurses and
physiotherapists. Each surgery is given economic respon-
sibility by the county council. While the structure of pri-
mary care demands financial responsibility on the part
of physicians, there are efforts to meet patients ? needs
and wishes and also to increase confidence in GPs. Due
to the patient-centred approach used in Swedish primary
care during recent decades, non-medical factors can in-
fluence the prescribing decision, such as organisation
structure or patient age and gender [5]. Another aspect
is that although GPs believe that costs should be taken
into account when prescribing, they are considered sec-
ondary to clinical effectiveness and safety, whilst individualpatient need is emphasized above other forms of rational-
ity or notions of opportunity costs. Conflict might be ap-
parent between a policy of cost containment and GPs?
resistance to cost-cutting [6]. At the same time, influences
from both patients and the pharmaceutical industry put
pressure on the doctor [7]. An interesting phenomenon is
that physicians deny changing their prescribing habits ac-
cording to patients? wishes as a result of advertising from
the pharmaceutical industry addressed directly to the pub-
lic, but feel pressure to justify their prescribing habits [8].
Meanwhile, doctors with the most visits per week are the
most likely to prescribe medicines according to patients?
wishes, even though they do not consider finding a med-
ical reason for that [9]. Another important aspect is that
GPs in Sweden do not have a gatekeeper role and the pa-
tients are free to consult other specialists without a refer-
ral [10]. The patients? drug list might thus contain drugs
prescribed by several physicians. According to the regula-
tions of the Swedish National Board of Health and
Welfare, the GPs have the responsibility for their own pre-
scribed drugs, but should even, if possible, inform them-
selves about other drugs that the patient uses and assess
whether the current prescription is appropriate [11]. How-
ever, GPs? understanding of responsibility for patients?
medication lists varies [12] and lower adherence to medi-
cation guidelines could potentially arise. The prescribing
decision is therefore multifaceted and strategies that influ-
ence prescribing patterns must take the abovementioned
underlying factors into account.
In the Swedish county of Sk?ne, the local drug and thera-
peutic committee (DTC) develops treatment guidelines and
publishes an annual list containing recommended drugs
based on medical evidence but also economic consider-
ations. The DTC works within multidisciplinary networks
including GPs, secondary-care specialists, district nurses
and pharmacists. The networks provide medication guide-
line lists for different specialities such as urology, psych-
iatry and dermatology, and sub-specialties of internal
medicine such as endocrinology and ischemic heart dis-
eases. They present the guidelines in a small booklet.
More detailed background information is available in print
and on the internet. Each network includes at least one
GP. There is a special section for drug therapy in the eld-
erly, including dosage reduction recommendations and a
list of potentially inappropriate medications in elderly pa-
tients. This is especially important since multi-morbidity
and polypharmacy are common in the elderly, which
means that multiple treatment guidelines have to be taken
into account.
In addition to the published list, the guidelines are also
spread through academic detailing at primary care cen-
tres and an annual local informative conference.
There is no clear evidence that locally developed
guidelines have a better effect on GPs ? adherence to
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lines, and there is an ongoing debate in Sweden as to
whether the DTCs should focus on a consensus national
list instead of each providing one list [13]. However, the
role of knowledge exchange through professional net-
working has been suggested to be an important factor
for transferring evidence into practice [14].
To increase compliance with local treatment guide-
lines, it is important to get a deeper understanding of
GPs? attitudes to them. Previous Swedish research has
explored Swedish GPs? attitudes towards evidence-based
guidelines in general using focus groups as the study ap-
proach [15]. The aim of this study was to explore GPs?
attitudes towards locally developed treatment guidelines
and the factors that affect adherence.
Methods
In previous studies we assessed the effects of different
intervention methods on GPs? adherence to medication
guidelines [16,17]. The qualitative design of the present
study was chosen in order to get a deeper understanding
of Swedish GPs ? attitudes towards local guidelines.
Focus groups have been widely used as an effective tech-
nique to explore the attitudes and needs of medical staff
[18]. The method uses open-ended questions, allowing
participants to approach the studied issues from a per-
sonal point of view. However, the debate within the group
facilitates expression of beliefs and attitudes left undevel-
oped in an individual interview.
For practical reasons we chose to invite pre-existing
focus groups of GPs with different experiences and gen-
ders, working at both private and public health care cen-
tres. The GPs did not interact with each other on a daily
basis but had regular meetings every month.
Formal approval was obtained from the local DTC, which
develops and publishes treatment guidelines annually.
Three focus group interviews were held. The first inter-
view was performed by a moderator (ELS) with prior ex-
perience of leading focus group interviews. An assistant
(VM) took notes during the interviews in order to recall
impressions of non-verbal communication between the
participants during the analysis. The researchers switched
roles in the second and third interviews. All three inter-
views were performed using a semi-structured interview
guide.
Participants
The GPs in the focus groups were recruited to the study
through an invitation letter. In Sk?ne, GPs from both
public and private health care centres have the possibil-
ity to meet regularly in previously established continuing
medical education (CME) groups to discuss patient cases
or different medical, practical or scientific issues [19]. Be-
cause of the assumed difficulty in creating new groups, westrategically invited all the pre-established CME groups in
Sk?ne to participate in the study. The groups usually con-
tain 6? 12 GPs of different age, gender and experience,
from different public and private health care centres. The
groups are used to interacting and debating, and feel com-
fortable expressing and sharing opinions. The invitation
letter, sent by e-mail, contained information about the aim
of the study and an informed consent form, and offered
the possibility to perform the interviews at the CME
group? s regular time and place of meeting.
Interview questions were created with an emphasis on
the following themes:
 Attitudes towards guidelines
 The impact of using guidelines on the doctor-patient
relationship.
Analysis
The interviews were audio recorded, transcribed verba-
tim and studied by the first and last authors using the-
matic content analysis [20,21]. After the transcribed
interviews and additional notes had been read, the text
was divided into meaning units and condensed. Units
with similar content were compiled into different sub-
categories, categories and themes, and the results were
discussed until a consensus was reached. The method is
conventional inductive content analysis with codes and
categories derived from data during analysis [22].
Ethical approval
The study has received ethical approval from the Regional
Ethical Review Board in Lund (case no: 2013/392).
Results
Three focus group discussions were held with a total of
17 participants, with 5, 5 and 7 GPs in groups 1, 2 and
3, respectively. The characteristics of the participants are
shown in Table 1.
An example of the text condensation in meaning units
is shown in Table 2.
Seven categories emerged during the coding process
(Table 3). The categories were grouped into two main
themes: GP-related influencing factors and External
influencing factors.
GP-related influencing factors
The first category included in this theme was ? Expecta-
tions and perceptions about existing local guidelines ?
(Table 4). GPs stated unanimously during the discus-
sions that they perceive guidelines as a form of support,
that they do not feel bound by them but feel safe when
using them. They also stated that they feel free to delib-
erately deviate from guidelines if necessary and expected
the existence of second and third choice drug on the list
Table 1 Characteristics of the participants





1 A F 57 54 20 20 Public
B F 54 25 Public
C F 50 15 Public
D F 45 16 Public
E F 58 30 Private
2 A M 53 53 10 10 Public
B F 61 33 Public
C F 64 35 Public
D F 34 4 Public
E F 38 3 Public
3 A F 35 40 7 5 Public
B F 48 5 Public
C M 41 10 Public
D F 48 5 Private
E M 35 5 Public
F F 40 8 Public
G M 33 2 Public
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that the aim of guidelines was cost containment and also
that guidelines focus primarily on drug costs and not on
the patient. A majority of GPs perceived the local guide-
lines as time saving.
The second category was ? Knowledge about evidence-
based prescribing? . Although participants unanimously
agreed that drug treatment should be evidence based, all
of them reported a lack of time to self-inform about newTable 2 Example of text condensation and coding
Theme GP-related influencing factors
Category Beliefs about adherence to guidelines
Final coding Reported adherence behaviour in
everyday practice




Condensed meaning unit In the case of migraine drugs, when I
did not have enough experience to say
that the more expensive drugs were








Meaning unit ?? and an area where I? ve benefited
from them ? (guidelines) ? in
agreement with the patient or against
the patient? s will ? is when they want
migraine drugs, triptans, more expensive
ones ? and when I didn ? t have enough
experience to say that that the more
expensive ones were better, I supported










widrugs or therapy recommendation changes. They also re-
vealed different levels of knowledge about the existence of
and use of IT-based guidelines. All the GPs reported easy
access to guidelines in a paper folder and welcomed the
annual DTC-arranged conference with information about
guidelines.
The category ? Trust in development of guidelines?
showed that all the GPs welcomed the detailed background




as decided that the insulin kind
uld change to another, cheaper
e, and soon afterwards it would
ange back again, but I have learned
m previous experience and have
t changed anything yet.
When I feel unsure I stick
to the guidelines.
we were supposed to change from
usual insulin that we had used many
rs to a cheaper one, and it is a lot
work if you are going to change it
all patients, and then after a couple
months they lowered the price of the
t one, so there was no difference any
re. But I have some previous experience
d have not changed anything yet, but
ll wait and see what happens. ?
? You feel sometimes that
you should be more informed,
but if I feel unsure I stick to
the guidelines ? .
Table 3 Categories and themes
Categories Themes




Knowledge about evidence-based prescribing
Trust in development of guidelines
Beliefs about adherence to guidelines
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formed about the decision process presented by the DTC
based on background research about the recommended
drugs. A historic change in attitude towards the DTC
among GPs was described, with a more positive attitude
and greater trust during recent years. Different levels of
knowledge about how the guidelines were formed were re-
vealed; however, trust in the DTC was described as being
more important. Several GPs expressed curiosity about
the structure of the local DTC and its work on developing
guidelines.Table 4 Categories and quotations for the theme ? GP-related
Category Quotations
Expectations and perceptions about
existing local guidelines
?? and then I feel free, that if it
something else ??
?? it is easy to check with the
but on the other hand I save tim
Knowledge about evidence-based
prescribing
? It has a lot to do with our stres
at our drugs, what there is and
have time to do it. Instead it is e
? A good thing to bring up, I thin
prescriptions] are there, so it is v
? I didn ? t even know that the gui
Trust in development of guidelines ?? then I wonder a little bit? t
guideline, I mean ? we don? t k
?? then I wonder, why does it h
the patients different??
? The background information? Y
wouldn? t have been as ? satisf
they considered and how the d
? But it feels quite uncomfortable
about, and they cost a lot, but y
Beliefs about adherence to guidelines ? A barrier would also be, as I sai
don? t know whether it will work
? Sometimes they come with dif
supposed to withdraw them an
goes along with it, because I ha
? It is actually aimed at GPs; hosp
we are doing ? they are suppo
? Yes, I agree with you, C ? if a
change the guidelines. Because
they already are??
aA Swedish-language medical periodical.A recurrent subject, spontaneously discussed by all three
groups, was the existence of local guidelines, with em-
phasis on the risk for unequal care in Sweden. Even if
most GPs agreed about the importance of local experience
and increased adherence if guidelines were local, some
GPs were concerned with different prescribing habits in
different regions and the consequences for the patients,
such as different access to expensive drugs.
An interesting aspect is that most of the GPs reported
caution with trying new drugs, using patient safety as an
argument; however, they agreed that the introduction of
new therapies might be delayed if primary care waits for
secondary-care specialists to prescribe them, e.g. drugs
for treatment of diabetes.
The category ? Beliefs about adherence to guidelines ?
revealed several dimensions with attitudes towards both
GPs? own and others ? prescribing. Most of the GPs
agreed that prescriptions should be based on guidelines.
The frequency of guideline updates was discussed and
some GPs requested more frequent updates than the
current annual ones, with faster introduction of new
drugs. However, a majority of GPs reported lower adher-
ence if recommendations changed often.influencing factors?
doesn? t work with these basic drugs, it ? s not a problem to prescribe
list ? and maybe I don? t have the same critical judgement as before,
e, because I perhaps wouldn? t have had the time anyway ??
s, that we don? t have the time to sit and read L?kartidningen a or to look
what the options are ? it is about our time ? that we actually don? t
asier to reach for something like this ? just as you say ??
k, is the new electronic medical records system, PMO, that [the
ery easy to prescribe a recommended drug, which is very positive? .
delines were there, where do you find them??
hey are after all human beings ? these groups who sit and write the
now how active and good the doctors in these groups are ??
ave to be local, does it have to be different ? in every region ? are
es, it is very robust and good. If I didn? t have that book I perhaps
ied or had the same confidence, because I can ? read about what
rugs work? .
, because they? re new drugs that we ? ve heard so many good things
ou sit there and wonder ? well ? nobody else tries it ??
d, a lack of options. It is a barrier to following guidelines, because you
in the next step ??
ferent pills from the hospital, which they don? t need, and then we are
d prescribe the recommended ones. I can say that often the patient
ve the book there with the guidelines ??
ital doctors don? t read it.? ? Sometimes it feels that they don? t know what
sed to follow the guidelines for the drug ? but I don? t think they do??
patient has a drug that works I don? t change it either just because they
? I don? t want to make the poor old patients more confused than
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care practice (Table 1). The second group included phy-
sicians with a great range of experience and the debate
within the group was dominated by the more experi-
enced GPs, the youngest having a more passive and con-
firmatory role. The third group, which included younger
physicians with shorter experience, expressed a greater
concordance of opinions regarding the acceptance of
guidelines as a prescribing tool, explaining it as the result
of early training in following evidence-based practice.
A majority of the participants expressed concerns
about having difficulties managing other doctors ? pre-
scribing and feeling uncomfortable changing prescrip-
tions according to guidelines if the patient had multiple
prescribers. Some GPs described strong beliefs that
guidelines were directed to primary care and were not
compulsory for hospital doctors or private secondary
care specialists.
External influencing factors
The first category in this theme was ? Patient-related
aspects ? (Table 5), where patient safety was described as
an important factor influencing the prescribing decision.
A majority of GPs reported deviation from guidelines if
a drug caused adverse drug reactions or if changing the
drug would result in lower compliance with treatment.
Patient safety was ranked as more important than main-
taining a good patient-doctor relationship, e.g. regarding
prescription of antibiotics. GPs reported the belief that
patients ? expectations might sometimes be different from
those of doctors; however, it was unusual for patients to
be unwilling to change drug therapy. A majority of GPsTable 5 Categories and quotations for the theme ? External in
Category Quotations
Patient-related aspects ? Yes, you should never experiment wit
This is why I think that we GPs are very
before I prescribe it ??
? You might think so, but the patient m
? ? I think it is very important not to g
feels important to explain to the patien
compromise a bit on the patient-docto
Drug industry-related aspects ? A conflict arises sometimes. Some pat
want another drug and ? insist ??
? We don? t know anything about that. W
?? and then you think about how life
indoc ? formed ? (laughs)?
Health economic aspects ?? I think that it is OK to save money o
of that kind or something else ? the b
?? but there is a lot of focus on econo
compared to other drugs ? so from t
? I am not really sure if the economy pa
? The goal is to save money, I suppose,
health care centres ? so of course it mreported a belief that patients have more trust in drugs
prescribed in hospitals, leading to difficulties in changing
therapy according to guidelines in primary care. Some
GPs felt uncomfortable about not being able to always
meet patients? expectations. GPs also believed that patients
might feel safe knowing that GPs adhere to guidelines but
that patients usually have little knowledge about the exist-
ence of guidelines. Patient-adapted information about
guidelines was believed to increase compliance and safety,
to benefit the patient-doctor relationship, and to be a bet-
ter alternative to drug advertising from the pharmaceutical
industry. The importance of dialogue with the patient was
a recurrent issue and a majority of the GPs reported that
guidelines facilitated the patient-doctor relationship.
The category ? Drug industry-related aspects ? in-
cluded GPs ? statements about difficulties in managing
direct-to-consumer commercials about drugs and their
impact on patients. Some GPs wondered about possible
influences of the drug industry on the local DTC. The
GPs described an historical change in how GPs get infor-
mation about new drugs as a shift from information
from the drug industry to objective academic detailing
from the DTC.
The category ? Health economic aspects ? included
GPs? statements about how economic considerations
should or should not influence adherence to guidelines.
The GPs expressed a feeling of economic responsibility
for both patients and society, revealing a two-sided atti-
tude and a dilemma faced in the prescribing situation.
Some GPs reported a belief that guidelines take cost
efficiency into account more than patients ? individual
needs. A subject largely discussed in the groups wasfluencing factors?
h patients ? or expose them to risk of injury. It is very important.
careful with new drugs. I prefer to wait a while with a new drug
ay think differently ??
ive in, at least in those cases with tetracycline versus penicillin, it
t the risk of bacterial resistance and so on ? so there you can
r relationship ??
ients are so well-read and influenced by the media and sometimes
e don? t know if somebody there is on Pfizer ? s board ? or is biased ??
was before the [local] guidelines even existed. ? we were drug industry
n things you can save money on ? maybe to be able to do more tests
udget is not unlimited, so I usually think that this is not a problem.?
my here, more focus on economy than on the pharmacological benefit
hat point of view it is highly controlled ??
rt motivates us ??
and more and more of the drug costs are transferred to the primary
atters ??
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both reluctance and understanding, describing the eco-
nomic perspective as both a barrier and a motivator for
adherence to guidelines. A majority of the GPs reported
understanding of the necessity of priorities in primary
care, but also a negative attitude towards the influence of
economic terms on the prescribing decision. The core mo-
tivators for adherence to guidelines were found to be the
time-saving aspect, trust in evidence-based market-neutral
guidelines, patient safety and the feeling of economic re-
sponsibility for both patients and society. Main barriers to
adherence were cost containment as a decision factor in
developing guidelines, multiple prescribers with unclear
responsibility for patients? medication lists and drug indus-
try information addressed directly to the public.
Discussion
Main findings
We found two main themes describing GPs? attitudes to-
wards local treatment guidelines: GP-related influencing
factors and External influencing factors.
The attitudes were grouped into seven main categor-
ies: Expectations and perceptions about existing local
guidelines, Knowledge about evidence-based prescrib-
ing, Trust in development of guidelines, Beliefs about
adherence to guidelines, Patient-related aspects, Drug
industry-related aspects, and Health economic as-
pects. To rely on evidence-based guidelines and the
time-saving benefit of using local guidelines were de-
scribed as key motivating factors for adherence, suggest-
ing that understanding of the development process and
easy access to local guidelines are factors with big impli-
cations for future guideline design and implementation.
Patient safety was reported to be more important than
adherence to guidelines or maintaining a good patient-
doctor relationship. GPs described both positive and
negative attitudes to cost containment, which was per-
ceived both as a motivating factor and a barrier for ad-
herence to guidelines. GPs expressed concerns about
difficulties with adherence to guidelines while managing
drugs from other prescribers and drug industry informa-
tion addressed directly to the public.
Strengths and limitations
Previous research has focused on GPs? adherence to nation-
ally developed guidelines [9,23,24], using a questionnaire-
based approach. We found no previous qualitative re-
search with focus groups studying GPs? attitudes towards
adherence to local guidelines, which is a novel aspect of
this study.
Focus groups as a qualitative research method have
been approached from different theoretical point of
views. For instance, social contextual constructivist re-
searchers address the ? process ? of interaction amongindividuals, in a specific context in which people live
and work, and recognize that the researcher ? s own back-
ground shapes their interpretation [25]. Social contextual
constructivists emphasize the importance of the re-
searcher ? s reflexivity and the context-dependent method.
The realist theoretical framework focuses on reliability
and validity in qualitative studies in order to present the
presumed only existing reality [26]. Methodological
tensions have been described between contextual con-
structionist and realist theory frameworks behind focus
groups [27]. According to contextual constructionism,
pre-existing groups may provide ? naturalistic? exchanges
by encouraging participation by people who are reluctant
to be interviewed or feel they have nothing to say [18].
From a realistic point of view pre-existing groups should
be avoided given their potential for bias [28]. We believe
that the strategic use of pre-existing groups of GPs with
different experience and gender, working at both private
and public health care centres and with previous contact
and familiarity with the debate within the group was a
strength of the study. Five to seven participants are recom-
mended for focus groups and we managed to include at
least five GPs in each group. Since the aim of the study
was to understand the factors that affect adherence to
guidelines, and not to generalize the results, we consider
17 participants to be satisfactory.
There was a general concordance of opinions within
the groups; however, the interviews created a debate
allowing the participants to express a great variety of at-
titudes towards particular issues, such as the frequency
of updates and economic aspects, which increased the
credibility of the results. These interesting aspects of dif-
ferent group dynamics suggest that even if heteroge-
neous groups might facilitate a debate, great variation in
professional experience is a possible limiting factor, less
experienced doctors being more hesitant in expressing
their opinions. However, including GPs with different
levels of experience might have increased the transfer-
ability of the results of this study.
One of the researchers (VM) knew 12 of the 17 partic-
ipants as colleagues, which could be both an advantage
and an obstacle. Her role as a GP might have encour-
aged free debate due to an assumed mutual understand-
ing of the cultural context the participants worked in.
However, no specific reactions on this matter were dis-
cussed or observed. VM is also a member of the local
DTC and her role as an objective researcher in the study
with no links of an economic or employment nature was
stressed prior to the interviews. She also explained her
role as a researcher in order to avoid addressing debate
questions related to her pre-understanding of the dis-
cussed topic. However, even if data collection and ana-
lysis were performed with objective reflexivity and with
continuous awareness of her pre-understanding of the
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tion of the study. The second researcher present during
the interviews (ELS) had a background as a social
worker and had no previous contact with the partici-
pants or pre-understanding of the studied subject. Due
to the researchers ? different levels of pre-understanding,
they switched role during the interviews. This might
have served as a strength by increasing the dependability
of the results.
The GPs in this study reported strong adherence. How-
ever, international data show that GPs overestimate their
adherence to guidelines, suggesting that self-reported ad-
herence might not correlate well with actual prescribing
behaviour and should not be used as the sole measure
of guideline adherence [29]. No prescribing data were
collected as we did not aim to assess prescribing behav-
iour. This means that we cannot draw any conclusions
from this study about Swedish GPs? adherence to local
guidelines.
Comparison with existing literature
As previously described in other studies, Swedish GPs
often believe that treatment guidelines are useful in
practice and generally have a positive attitude to them
[24]. They see prompt and pragmatic benefits as a strong
motivating factor, though differences exist between GPs
[15]. However, a meta-analysis of qualitative research
shows that GPs? attitudes towards treatment guidelines
may be influenced by the purpose of the guidelines and
that trust might be more important than access when
implementing them [23], similar to the results in our
study.
The GPs in this study did not report that adherence to
guidelines would lead to a poorer patient-doctor rela-
tionship. The results are different from international
data. A Canadian study showed that the use of recom-
mendation lists based on a controlled replacement
model led to poorer patient contacts, increased stress
for doctors and increased the frequency of contacts with
the healthcare system [30]. A British study showed that
a strong feeling of clinical autonomy and resistance to
economic decisions caused a sceptical attitude towards
clinical guidelines and that emphasis on cost-effectiveness
might be counterproductive [31]. The participants in our
study reported concerns about the negative effect of eco-
nomic aspects in forming guidelines, findings similar to
those of other studies [32]. However, cost containment
was not frequently reported to be a negative factor in deci-
sion making or to affect the patient-doctor relationship.
These findings, unlike those from other studies, might be
due to the unique social and professional context Swedish
GPs work in, in larger multi-professional surgeries with
shared economic responsibility. However, the impact of
different organisational contexts on GPs? attitudes towardsadherence to guidelines was not studied in this paper. The
results might also mirror the historical change in attitudes
towards drug information. The participants described a
paradigm shift in GPs? attitudes towards drug information
sources during recent decades, with an increasingly posi-
tive attitude towards academic detailing provided by the
local DTC instead of drug industry-supplied information.
Younger GPs reported higher adherence to local guide-
lines. This is consistent with findings from a recent Swedish
study [33], which showed that Swedish GPs who were
older or had more experience were more positive to drug
industry-supplied information than younger GPs. Fre-
quent changes in recommendations were viewed both
positively and negatively, with great variation between the
participants. GPs reported trust in evidence-based guide-
lines, but also interest in the operations of the local DTC.
However, they did not express opposition to a top-down
managerial initiative about prescribing quality. Our find-
ings indicate that transparency in forming guidelines, such
as information about the structure and methods of the
local DTC together with regular academic detailing about
the guidelines, might increase confidence in the local DTC
and thus enhance adherence. A recent Canadian study
showed that GPs believe that involvement of frontline
practitioners in developing guidelines might facilitate im-
plementation by maximizing the objectivity of recommen-
dations [34]. This suggests that increased knowledge
among Swedish GPs about the structure of DTCs, which
involve GPs in the development of guidelines, might fur-
ther enhance adherence.
GPs described the patient-doctor encounter, with em-
phasis on informing the patient about guidelines if ne-
cessary, as very important. This factor has been found to
enhance adherence to guidelines, such as recommenda-
tions for prudent antibiotic prescribing [35].Conclusions
The Swedish GPs in this study reported that patient
safety, the time-saving aspect, trust in evidence-based
market-neutral guidelines and the patient-doctor en-
counter, with emphasis on informing the patient were
core motivators for adherence to guidelines. Main bar-
riers to adherence were cost containment as a decision
factor in developing guidelines, multiple prescribers with
unclear responsibility for patients? medication lists and
drug industry information addressed directly to the pub-
lic. Future studies should explore the need for transpar-
ency in forming and implementing guidelines, which
might potentially increase adherence to evidence-based
treatment guidelines in primary care.
Abbreviations
GP: General practitioner; DTC: Drug and therapeutic committee;
CME: Continuing medical education.
Milos et al. BMC Family Practice 2014, 15:199 Page 9 of 9
http://www.biomedcentral.com/1471-2296/15/199Competing interests
The authors declare that there is no conflict of interest. The first author (VM)
was at the time of the study a member of Sk?ne County ? s DTC. The study was
financed by funding from the Southern Medical District and Lund University.
Authors ? contributions
VM and ELS were involved in the conception and design of the study, the
acquisition, analysis and interpretation of data and the drafting of the
manuscript, and have given final approval of the version to be published. TW
and PM were involved in the conception and design of the study and the
regular revision of manuscript drafts, and have given final approval of the
version to be published. All authors read and approved the final manuscript.
Acknowledgements
We are indebted to Stephen Gilliver for his expertise and invaluable advice
in proofreading the manuscript.
Disclaimer
The opinions or assertions in this article are the views of the authors and are
not to be construed as official or as necessarily reflecting the views of the
Swedish Medical Products Agency, where one of the authors is employed.
Author details
1Department of Clinical Sciences in Malm?, Lund University, Malm?, Sweden.
2Medical Products Agency, Department of Medicine Usage, Uppsala and
Sahlgrenska Academy, Department of Public Health and Community
Medicine, Unit of Social Medicine, Institute of Medicine, University of
Gothenburg, Gothenburg, Sweden. 3Department of Clinical Sciences in
Malm?, Center for Primary Health Care Research, Lund University, Clinical
Research Centre (CRC), Sk?ne University Hospital, building 28, floor 11, Jan
Waldenstr?ms gata 35, 205 02 Malm?, Sweden.
Received: 4 August 2014 Accepted: 17 November 2014
References
1. Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson
LL: Multifaceted national and regional drug reforms and initiatives in
ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon
Outcomes Res 2009, 9(1):63 ? 85.
2. Bennett NL, Casebeer LL, Kristofco R, Collins BC: Family physicians ?
information seeking behaviors: a survey comparison with other
specialties. BMC Med Inform Decis Mak 2005, 5:9.
3. Gabbay J, le May A: Evidence based guidelines or collectively constructed
? mindlines ? ? Ethnographic study of knowledge management in primary
care. BMJ 2004, 329(7473):1013.
4. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, Alvarez V, Dittus
RS, Speroff T: Clinical inertia: a common barrier to changing provider
prescribing behavior. Jt Comm J Qual Patient Saf 2007, 33(5):277? 285.
5. Stewart RE, Vroegop S, Kamps GB, van der Werf GT, Meyboom-de Jong B:
Factors influencing adherence to guidelines in general practice. Int J
Technol Assess Health Care 2003, 19(3):546? 554.
6. Prosser H, Walley T: A qualitative study of GPs? and PCO stakeholders ?
views on the importance and influence of cost on prescribing. Soc Sci
Med 2005, 60(6):1335 ? 1346.
7. Kersnik J, Peklar J: Attitudes of Slovene general practitioners towards
generic drug prescribing and comparison with international studies.
J Clin Pharm Ther 2006, 31(6):577? 583.
8. Allison-Ottey SD, Ruffin K, Allison KB: ? To do no harm ? survey of NMA
physicians regarding perceptions on DTC advertisements. National
Medical Association. J Natl Med Assoc 2002, 94(4):194 ? 202.
9. Fortuna RJ, Ross-Degnan D, Finkelstein J, Zhang F, Campion FX, Simon SR:
Clinician attitudes towards prescribing and implications for interventions
in a multi-specialty group practice. J Eval Clin Pract 2008, 14(6):969? 973.
10. Wettermark B, Bergman U, Krakau I: Using aggregate data on dispensed
drugs to evaluate the quality of prescribing in urban primary health care
in Sweden. Public Health 2006, 120(5):451? 461.
11. The Swedish Board of Health and Welfare regulations on drug
prescribing in the Swedish health Service. Socialstyrelsen. SOSFS. 2000.
Available from: [http://www.socialstyrelsen.se/sosfs/2000-1/]. Accessed
October 10, 2014.12. Rahmner PB, Gustafsson LL, Holmstrom I, Rosenqvist U, Tomson G: Whose
job is it anyway? Swedish general practitioners ? perception of their
responsibility for the patient ? s drug list. Ann Fam Med 2010, 8(1):40 ? 46.
13. Skoglund I: Prescribing drugs in primary health care. Thoughts,
information strategy and outcome. Doctoral dissertation. 2012. Available
from: https://gupea.ub.gu.se/bitstream/2077/29712/1/gupea_2077_29712_1.
pdf. Accessed October 8, 2014.
14. Greenhalgh T: What is this knowledge that we seek to ? exchange? ?
Milbank Q 2010, 88(4):492? 499.
15. Skoglund I, Segesten K, Bjorkelund C: GPs? thoughts on prescribing medication
and evidence-based knowledge: the benefit aspect is a strong motivator. A
descriptive focus group study. Scand J Prim Health Care 2007, 25(2):98? 104.
16. Milos V, Rekman E, Bondesson A, Eriksson T, Jakobsson U, Westerlund T,
Midl?v P: Improving the quality of pharmacotherapy in elderly primary
care patients through medication reviews: a randomised controlled
study. Drugs Aging 2013, 30(4):235? 246.
17. Milos V, Jakobsson U, Westerlund T, Melander E, M?lstad S, Midl?v P:
Theory-based interventions to reduce prescription of antibiotics ? a
randomized controlled trial in Sweden. Fam Pract 2013, 30(6):634 ? 640.
18. Kitzinger J: Qualitative research. Introducing focus groups. BMJ 1995,
311(7000):299 ? 302.
19. Eliasson G, Mattsson B: From teaching to learning. Experiences of small
CME group work in general practice in Sweden. Scand J Prim Health Care
1999, 17(4):196? 200.
20. Graneheim UH, Lundman B: Qualitative content analysis in nursing
research: concepts, procedures and measures to achieve
trustworthiness. Nurse Educ Today 2004, 24(2):105? 112.
21. Burnard P, Gill P, Stewart K, Treasure E, Chadwick B: Analysing and
presenting qualitative data. Br Dent J 2008, 204(8):429? 432.
22. Hsieh HF, Shannon SE: Three approaches to qualitative content analysis.
Qual Health Res 2005, 15(9):1277? 1288.
23. Carlsen B, Bringedal B: Attitudes to clinical guidelines ? do GPs differ from
other medical doctors? BMJ Qual Saf 2011, 20(2):158 ? 162.
24. Axelsson MA, Spetz M, Mellen A, Wallerstedt SM: Use of and attitudes
towards the prescribing guidelines booklet in primary health care
doctors. BMC Clin Pharmacol 2008, 8:8.
25. Creswell JB: Qualitative Inquiry & Research Design. Choosing Among Five
Approaches. 3rd edition. Thousand Oaks: Sage Publications Ltd; 2013.
26. Madill A, Jordan A, Shirley C: Objectivity and reliability in qualitative
analysis: realist, contextualist and radical constructionist epistemologies.
Br J Psychol 2000, 91(Pt 1):1 ? 20.
27. Freeman T: ? Best practice ? in focus group research: making sense of
different views. J Adv Nurs 2006, 56(5):491? 497.
28. Krueger RA: Analyzing focus group interviews. J Wound Ostomy
Continence Nurs 2006, 33(5):478? 481.
29. Adams AS, Soumerai SB, Lomas J, Ross-Degnan D: Evidence of self-report bias
in assessing adherence to guidelines. Int J Qual Health Care 1999, 11(3):187? 192.
30. Suggs LS, Raina P, Gafni A, Grant S, Skilton K, Fan A, Szala-Meneok K: Family
physician attitudes about prescribing using a drug formulary. BMC Fam
Pract 2009, 10:69.
31. Watkins C, Timm A, Gooberman-Hill R, Harvey I, Haines A, Donovan J:
Factors affecting feasibility and acceptability of a practice-based educational
intervention to support evidence-based prescribing: a qualitative study. Fam
Pract 2004, 21(6):661? 669.
32. Carlsen B, Norheim OF: ? What lies beneath it all??? an interview study of
GPs? attitudes to the use of guidelines. BMC Health Serv Res 2008, 8:218.
33. Skoglund I, Bjorkelund C, Mehlig K, Gunnarsson R, Moller M: GPs? opinions
of public and industrial information regarding drugs: a cross-sectional
study. BMC Health Serv Res 2011, 11:204.
34. Kastner M, Estey E, Hayden L, Chatterjee A, Grudniewicz A, Graham ID,
Bhattacharyya O: The development of a guideline implementability tool
(GUIDE-IT): a qualitative study of family physician perspectives. BMC Fam
Pract 2014, 15:19.
35. Strandberg EL, Brorsson A, Hagstam C, Troein M, Hedin K: ? I?m Dr Jekyll and Mr
Hyde? : are GPs? antibiotic prescribing patterns contextually dependent? A
qualitative focus group study. Scand J Prim Health Care 2013, 31(3):158? 165.
doi:10.1186/s12875-014-0199-0
Cite this article as: Milos et al.: Swedish general practitioners ? attitudes
towards treatment guidelines ? a qualitative study. BMC Family Practice
2014 15:199.
